Detalhe da pesquisa
1.
Treatment with a New Peroxisome Proliferator-Activated Receptor Gamma Agonist, Pyridinecarboxylic Acid Derivative, Increases Angiogenesis and Reduces Inflammatory Mediators in the Heart of Trypanosoma cruzi-Infected Mice.
Front Immunol
; 8: 1738, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29312293